Glomangiomatosis is a rare condition that causes many glomus growths, usually in the skin and soft tissues. These areas often look like bluish or purple lumps and they can be tender or painful, especially with pressure or cold. Glomangiomatosis often starts in childhood or early adult life and may persist long term, although not everyone will have the same experience. It is usually not life-threatening, but larger or deeper areas can cause ongoing pain and can affect movement or daily comfort. Treatment for Glomangiomatosis focuses on management and may include pain relief, surgery, laser treatment, or other procedures for bothersome lesions, and early symptoms of Glomangiomatosis are worth discussing with a specialist.
How many people live with Glomangiomatosis?
Glomangiomatosis is considered extremely rare, but no recent, reliable estimate of how many people live with it worldwide is consistently reported by major medical sources. The same is true in the United States, where a current national estimate for people living with glomangiomatosis does not appear to be available.
Overview
GlomangiomatosisSymptoms
Glomangiomatosis usually causes multiple soft, bluish-purple skin bumps or deeper lumps that can be tender, especially with pressure. Many living with glomangiomatosis notice them from childhood. The size, number, and location of these features can vary widely.
Outlook and prognosis
Glomangiomatosis often grows slowly, but pain and new lesions can build up over time. Outlook is usually good for life expectancy, though repeat treatments may be needed. Prognosis depends on how many areas are involved and whether surgery is possible.
Causes and risk factors
Glomangiomatosis is usually linked to a change in the GLMN gene, inherited from a parent or happening new early in development. The main risk factor is family history, while hormonal changes such as puberty or pregnancy may make symptoms more noticeable.
Genetic influences
Genetics can be very important in glomangiomatosis, especially when it runs in families. Some cases are linked to changes in the GLMN gene, but not everyone with glomangiomatosis has an identifiable genetic variant.
Diagnosis
Glomangiomatosis is usually diagnosed from its clinical features and imaging findings, especially when there are multiple painful bluish skin or soft-tissue spots. Doctors often confirm the diagnosis of Glomangiomatosis with a biopsy, and genetic tests may help in some families.
Treatment and drugs
Glomangiomatosis is usually managed with pain relief and removing or shrinking troublesome glomus growths, often with surgery or laser treatment. Some lesions are watched over time. Care is tailored to location, size, bleeding, and pain.
Symptoms
Glomangiomatosis often shows up in everyday life as clusters of soft blue, purple, or skin-colored spots under the skin that may hurt when pressed or knocked. For many people with Glomangiomatosis, the marks are most noticeable on the arms, legs, hands, or feet, and some may find that cold weather or tight shoes make them more uncomfortable. These areas are often present from childhood or early adulthood and can slowly become more noticeable over time.
Many living with glomangiomatosis notice blue, purple, or dark red spots or patches just under the skin. The early features of Glomangiomatosis are often a few small marks that can look like a birthmark, a bruise, or a cluster of tiny veins.
The affected areas may feel soft, rubbery, or slightly raised rather than firm. Some flatten a little when pressed, while others feel like small nodules under the skin.
Pain is often triggered by pressure, bumping, or cold instead of being constant all day. A tight waistband, a bag strap, or leaning on the area can make a spot suddenly feel sore.
Glomangiomatosis usually involves several spots rather than one isolated lump. They may stay grouped in one part of the body or appear in more than one area over time.
How people usually first notice Glomangiomatosis?
Glomangiomatosis is often first noticed when a child, teen, or young adult develops soft blue to purple skin bumps or plaque-like areas that can look like bruises but do not fade normally and may slowly become more noticeable over time. For many people, the first signs of glomangiomatosis are tenderness or sharp pain when the area is pressed, bumped, or exposed to cold, along with clusters of lesions on the arms, legs, or trunk. Sometimes doctors first recognize it because the spots are present from birth or early childhood, or because several family members have had similar painful vascular skin lesions.
Types of Glomangiomatosis
No distinct types of Glomangiomatosis are widely recognized.
Can I slow down the onset of symptoms?
At this time, there is no good evidence that lifestyle changes or medicines can meaningfully delay the start of symptoms in glomangiomatosis. This condition is usually driven by changes in the affected tissue, and sometimes inherited gene changes, so habits like healthy eating, exercise, and good sleep are still good for overall health but have not been shown to prevent it or clearly push symptoms back. There are no proven screening or preventive treatments to stop symptoms from starting, but regular follow-up can help find new lumps, skin changes, or pain early and make treatment easier if problems come up.
What genetics can tell you about symptoms
Yes. In many people with glomangiomatosis, changes in the GLMN gene are linked to whether these growths develop, and genetics can influence how many appear, where they occur, how painful they are, and whether they start in childhood or later in life. Even within the same family, symptoms can vary a lot, so genetics can give clues about the pattern of disease but usually cannot predict exactly how severe it will be for one individual.
Causes and risk factors
For many people with glomangiomatosis, the main cause is a change in the GLMN gene, and this change can be inherited or happen for the first time. Family history is one of the clearest glomangiomatosis risk factors, especially when close relatives also have it. Having a gene change doesn’t mean you’ll definitely develop the condition. Other biological factors may affect when glomangiomatosis appears and how extensive it becomes. No clear environmental or lifestyle causes have been proven, so the genetic causes of glomangiomatosis matter much more than diet, exercise, or everyday exposures.
What are the most common causes or risk factors?
Glomangiomatosis is most often caused by an inherited change in a gene that affects cells around small blood vessels, so many people living with it have a family history, although some cases happen for the first time in one person. The strongest known risk factor is having a parent or close relative with the condition, and it often begins in childhood or early adult life. There are no well-proven lifestyle or environmental causes, so it is not thought to be caused by diet, exercise, stress, or anything you did.
Environmental and biological risk factors
Glomangiomatosis is so rare that clear environmental and non-genetic biological risk factors have not been pinned down. Researchers are still exploring how outside influences interact with our inner biology. For now, most medical sources do not link glomangiomatosis to a specific exposure, infection, injury, or common health condition. This means the known environmental and biological risk factors for glomangiomatosis are limited.
No environmental exposure has been clearly shown to raise the chance of glomangiomatosis. This includes the usual categories doctors look for, such as toxins, infections, or radiation.
No common non-genetic biological factors have been proven to increase the likelihood of glomangiomatosis. Doctors do not currently use a standard body-based risk profile for this condition.
Glomangiomatosis is often recognized early in life, sometimes in childhood or young adulthood. This pattern suggests it usually starts long before later-life exposures are considered, but early timing itself is not a preventable risk factor.
Genetic risk factors
For many living with glomangiomatosis, the main inherited risk is a change in a gene called GLMN. These gene changes can run in families, although some begin for the first time in one person. Carrying a genetic change doesn’t guarantee the condition will appear. When doctors look at the genetic causes of glomangiomatosis, they also consider how it is passed down and why it can look very different from one family member to another.
GLMN gene: Most inherited cases of glomangiomatosis are linked to a harmful change in the GLMN gene. This gene helps control cells around small blood vessels, so a change in it can make these vessel-related growths more likely.
Family history: Glomangiomatosis often runs in families, so having an affected parent or close relative raises the chance of carrying the same gene change. The family pattern may be easy to miss because some relatives have only a few mild lesions.
Dominant inheritance: GLMN-related glomangiomatosis is usually passed down in an autosomal dominant pattern, meaning one altered copy of the gene is enough to increase risk. Each child of an affected parent has a 1 in 2, or 50%, chance of inheriting that change.
New genetic changes: Some people with glomangiomatosis have a new genetic change that was not inherited from either parent. This means the condition can still have a genetic cause even when there is no known family history.
Second-hit changes: In many cases, inheriting a GLMN change is only the first step. A second genetic change that happens later in a small group of cells may help trigger where and when lesions appear.
Variable expression: People with the same GLMN change can have very different experiences, which is one reason early symptoms of glomangiomatosis may be obvious in one relative but barely noticeable in another. Some family members who carry the change may have few signs or develop them later.
Lifestyle risk factors
Glomangiomatosis is not caused by lifestyle habits, but daily routines can influence pain, bleeding, skin irritation, and how much lesions interfere with activity. When people ask about lifestyle risk factors for Glomangiomatosis, the key issue is usually how lifestyle affects Glomangiomatosis symptoms rather than what causes it. The most helpful focus is on reducing trauma, pressure, and triggers that make lesions more painful or more likely to bleed.
Repeated bumps, friction, shaving cuts, or scratching can make glomangiomatosis lesions hurt more and may trigger bleeding or local swelling. Protecting affected areas during daily activities can reduce symptom flares and skin breakdown.
Tight shoes, restrictive clothing, prolonged sitting, or leaning on affected spots can increase tenderness in painful lesions. Reducing direct pressure may improve comfort and make walking, exercise, or work tasks easier.
Cold temperatures can worsen pain in some vascular skin lesions by increasing sensitivity and vessel constriction. Keeping affected areas warm may lessen cold-triggered discomfort and improve day-to-day function.
Contact sports or activities with frequent impact can aggravate lesions through repeated trauma and bruising. Lower-impact exercise is often easier to tolerate while still supporting fitness and mobility.
Risk prevention
For most people with glomangiomatosis, there is no proven way to prevent the condition itself, especially when it is linked to an inherited gene change. Prevention usually means lowering the chance of pain, bleeding, skin injury, or delays in care, and helping spot new growths early. Different people need different prevention strategies—there’s no single formula. Many living with glomangiomatosis do best with a mix of skin protection, trigger avoidance, and regular medical follow-up.
Bumps from glomangiomatosis can be painful and may bleed if they are rubbed, hit, or cut. Soft clothing, well-fitting shoes, and padding over easily bumped areas can help reduce daily irritation.
Repeated pressure or minor injuries can make some lesions more uncomfortable and more likely to bruise or bleed. For many, this can mean adjusting sports, tools, or work tasks that put stress on the same spot.
Some people with glomangiomatosis notice worse pain with cold or sudden temperature changes. Keeping affected areas warm and avoiding extreme cold may help limit flare-ups.
New lumps, growing areas, or changes in pain should be checked sooner rather than later, since early symptoms of glomangiomatosis can be mistaken for other skin problems. Prevention works best when combined with regular check-ups.
Can you prevent Glomangiomatosis?
No, there is no proven way to prevent glomangiomatosis, because it is usually linked to changes in genes or develops for reasons outside your control. If this condition runs in your family, speaking with a genetics specialist before having children may help you understand the chance of passing it on, but it cannot fully prevent it.
Transmission
Glomangiomatosis is not infectious, so it cannot be caught from someone else through touch, kissing, shared air, food, sex, or blood. For many living with Glomangiomatosis, the more useful question is how Glomangiomatosis is inherited: some cases are linked to a gene change that can be passed from parent to child.
If a parent carries that gene change, each child may have a 1 in 2, or 50%, chance of inheriting it, although the signs can vary a lot even within the same family. Some people with Glomangiomatosis are the first in their family to have it because the gene change happened new in them, rather than being inherited.
When to test your genes
Consider genetic testing if you have multiple painful bluish skin lesions, symptoms that began in childhood, or relatives with similar findings. Testing can confirm a glomulin-related condition, clarify whether family members may also be affected, and help guide surveillance, counseling, and treatment planning.
Diagnosis
Glomangiomatosis is usually diagnosed by putting together what the growths look and feel like, where they appear, and what imaging or tissue testing shows. Many living with glomangiomatosis first seek care because painful skin or soft-tissue lumps keep getting bumped by clothing, pressed when sitting, or become more noticeable over time. Getting a diagnosis is often a turning point toward answers and support. Because this condition is rare and can resemble other blood vessel or soft-tissue growths, confirmation often needs more than one test.
Doctors ask when the lesions first appeared, whether they are painful, and if they have changed in size, number, or color over time. A detailed family and health history can help because some cases have a genetic link.
The clinician examines the size, color, texture, and location of the lesions and checks whether touching them causes pain. This helps narrow the diagnosis of glomangiomatosis and separate it from more common vascular birthmarks or benign skin lumps.
Ultrasound or MRI can show how deep the lesions extend and whether nearby muscles, nerves, or blood vessels are involved. These scans are especially useful when glomangiomatosis affects larger areas or causes symptoms beneath the skin.
A small sample of tissue may be removed and examined under a microscope to confirm the diagnosis. Doctors look for the typical pattern of glomus-type cells around widened blood vessels, which helps distinguish this condition from other vascular tumors or malformations.
How is Glomangiomatosis diagnosed?
Doctors usually suspect glomangiomatosis from the pattern of slow-growing, often painful growths in the skin or deeper soft tissues and from the physical exam. Scans such as ultrasound or, more often, MRI can help show how deep the growths go and how much area is involved, but the diagnosis is usually confirmed with a biopsy, which means taking a small sample and looking at it under a microscope. If there are many growths or a family history, genetic testing may sometimes be offered to look for an inherited cause.
Stages of Glomangiomatosis
Glomangiomatosis does not have defined progression stages. This is because it is usually described by where the growths are, how deeply they spread into nearby tissue, and whether symptoms stay stable or change over time, rather than by a step-by-step course. Doctors usually start with a conversation about pain, swelling, skin changes, or a lump that keeps bothering you, since early symptoms of glomangiomatosis can look like other soft-tissue problems. Diagnosis and follow-up usually rely on an exam, imaging such as ultrasound or MRI, and a tissue sample under the microscope to confirm what the growth is.
Outlook and prognosis
The outlook for people with glomangiomatosis is usually favorable in terms of survival, because most cases behave as benign but locally infiltrative tumors rather than cancers that spread widely. The main long-term issues are chronic pain, swelling, functional impairment, and a high risk of local recurrence, especially when complete surgical removal is difficult because of diffuse growth or involvement of critical structures. Repeated procedures may be needed over time, and prognosis is often driven more by the location and extent of disease than by aggressive biology. Malignant transformation or metastasis appears to be very uncommon, so death directly from glomangiomatosis is rare. Overall, quality of life can be significantly affected in extensive cases, but life expectancy is generally near normal with appropriate monitoring and symptom-directed treatment.
Long-term effects
For many living with glomangiomatosis, the long-term picture depends mostly on how many areas are involved and where the growths are located. Long-term effects vary widely, from a few stable spots that change little over time to more widespread involvement that affects comfort, movement, or appearance. The long-term effects of glomangiomatosis are usually related to repeated pain, slow enlargement of lesions, and the burden of having a chronic condition over many years. In most cases, it does not spread through the body like cancer, but it can remain a lasting source of problems.
Pain is one of the most common long-term effects of glomangiomatosis, and it may flare with pressure, minor bumps, exercise, or cold temperatures. For many, this can mean avoiding tight clothing, skipping certain sports, or feeling sore after everyday contact that others would barely notice.
The affected areas may slowly enlarge or increase in number over time, especially from childhood into adult life. Some remain fairly stable for years, while others become more noticeable and cover a wider area.
When lesions involve a hand, foot, joint, or deeper soft tissues, they can make movement uncomfortable and reduce normal use of that area. Many people notice small adjustments like changing how they walk, write, lift, or grip because direct pressure can hurt.
Glomangiomatosis often leaves lasting visible skin changes, such as bluish or purple raised areas and uneven contours. These marks may become a long-term cosmetic concern, especially when they are on the arms, legs, or other easy-to-see places.
How is it to live with Glomangiomatosis?
Living with glomangiomatosis can mean living with clusters of glomus-related growths in the skin and soft tissues that may be painful, tender to pressure, or more noticeable over time, especially when clothing rubs, after minor bumps, or in cold temperatures. For many people, this can affect everyday choices like exercise, work tasks, sleep position, and what feels comfortable to wear, while the visible lesions can also weigh on confidence and body image. Family members and close friends may need to understand that the pain is real even when others cannot easily see it, and they may help with practical adjustments, emotional support, and planning around medical visits or procedures when symptoms flare.
Treatment and drugs
Treatment for glomangiomatosis depends on where the growths are, how many there are, and whether they are causing pain, bleeding, or problems with movement or daily activities. Many people with glomangiomatosis do not need urgent treatment, but painful or troublesome areas may be treated with surgery, laser treatment, or a procedure that blocks off the blood supply to the lesion. If first-line treatments do not help, specialists may try second-line options, especially when glomangiomatosis is widespread or comes back after treatment. Pain control, skin care, and regular follow-up are also important, because for many living with glomangiomatosis, treatment is about easing symptoms and protecting quality of life rather than curing the condition completely.
Can you cure Glomangiomatosis?
There is no sure cure for glomangiomatosis at this time, especially when the abnormal growths are spread out or hard to fully remove. Treatment can still help a lot by removing or reducing painful areas, controlling bleeding, and improving movement or comfort, most often with surgery and sometimes with other local treatments. Even after treatment, it can come back, so follow-up care is often needed.
Non-drug treatment
Living with glomangiomatosis often means dealing with tender skin or soft-tissue lumps that can hurt with pressure, cold, or minor bumps. Treatment is usually centered on easing pain, protecting sensitive areas, and deciding whether any bothersome growths should be removed or treated locally. Managing this condition often involves a mix of watchful follow-up, practical self-care, and procedures for spots that keep interfering with daily life. Because glomangiomatosis can vary a lot from one person to another, care is usually tailored to symptoms, location, and how much the lesions affect movement, sleep, or work.
Small or less bothersome areas may only need regular check-ins and occasional imaging if a deeper growth is suspected. This can help track changes in size, pain, or number over time without rushing into treatment.
Heat or cold sensitivity, friction, and pressure can make everyday tasks uncomfortable for many living with glomangiomatosis. Non-drug pain management for glomangiomatosis may include padding, warm clothing, activity changes, and learning which triggers are most likely to set pain off.
Soft shoes, cushioned clothing, gloves, or padding over tender spots can reduce daily irritation. Simple routines like avoiding repeated bumps or firm pressure can have lasting benefits.
When one or a few lesions cause ongoing pain or limit movement, surgery may be used to remove them. This can help most when the painful area is well defined, although new lesions can still appear elsewhere.
Your genes may have an impact on how drugs work for you
For people living with glomangiomatosis, treatment is usually based more on where the growths are, how painful they are, and whether they can be removed or treated locally, rather than on how their body is likely to process a medicine. At this time, there is no well-established evidence that common medicines used for pain or symptom relief in this condition are routinely chosen or dosed based on a person’s genetic makeup. The inherited change linked to glomangiomatosis is mainly helpful for confirming the diagnosis and understanding why it runs in some families, not for predicting a clearly different response to medication.
Pharmacological treatments
Glomangiomatosis often causes pain and tenderness in daily life, so medicines are usually aimed at symptom control rather than cure. There is no single standard drug treatment that reliably removes glomangiomatosis, and many living with glomangiomatosis also need procedures such as surgery, laser treatment, or sclerotherapy. Not everyone responds to the same medication in the same way. When doctors do use medication, the choice depends on how painful the lesions are, how widespread they are, and whether a specialist thinks a targeted drug may help.
Acetaminophen can help ease mild to moderate pain from glomangiomatosis, especially when lesions are sore after pressure or activity. It does not shrink the growths, but it may make day-to-day discomfort easier to manage.
Nonsteroidal anti-inflammatory drugs such as ibuprofen or naproxen may help with pain and throbbing in some people with glomangiomatosis. These medicines can irritate the stomach, affect the kidneys, or raise bleeding risk in some situations, so a clinician may check whether they are safe for you.
Numbing creams or patches containing lidocaine are sometimes used for small, very tender areas. For some people looking for treatment for glomangiomatosis pain, these can give short-term relief without affecting the rest of the body.
If the pain is burning, shooting, or hard to control, doctors may sometimes try medicines such as gabapentin or pregabalin. These drugs treat nerve-related pain rather than the lesion itself, and they can cause sleepiness or dizziness in some people.
Genetic influences
Glomangiomatosis can sometimes be influenced by genetics, especially when similar glomus-type growths show up in several relatives. In some families, changes in a gene called GLMN have been linked to these growths, and the change can be passed from an affected parent to a child, with a 50% chance in each pregnancy. Having a gene change doesn’t always mean you will develop the condition, and even within the same family, the number, size, and location of lesions can vary a lot. At the same time, many people with glomangiomatosis do not have a clear family history, so genes are not the whole story in every case. Understanding the genetic causes of glomangiomatosis can help with family planning, deciding whether relatives may need evaluation, and whether genetic counseling or testing could be helpful.
Is Glomangiomatosis genetic?
Genetics can be very important in glomangiomatosis, especially when it runs in families. Some cases are linked to changes in the GLMN gene, but not everyone with glomangiomatosis has an identifiable genetic variant.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a common, normal part of human biology and are found throughout the general population. Most do not directly affect health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a certain diagnosis, especially when several genes and environmental factors are involved. In some situations, however, a single well-understood variant in a particular gene is enough to confirm the diagnosis.
Pharmacogenetics—how genetics influence drug effects
For many people living with glomangiomatosis, treatment decisions depend partly on the underlying gene change, most often in a gene called GLMN, because this can help confirm that the skin or soft-tissue bumps are part of an inherited condition rather than a different kind of vascular growth. That genetic information is usually more helpful for diagnosis, family counseling, and planning care than for choosing a specific drug. At this point, there is no standard gene-targeted medicine that corrects the genetic cause of glomangiomatosis, so treatment is still mainly based on symptoms, such as pain, bleeding, or lesions that are growing or getting in the way of daily life. Genetics is only one factor, and the number of lesions, where they are located, and how deep they go often matter more when doctors decide between monitoring, procedures to remove or shrink them, and pain relief. If early symptoms of glomangiomatosis appear in several family members, genetic testing may help doctors recognize the condition sooner and avoid treatments aimed at the wrong diagnosis.
Interactions with other conditions
Glomangiomatosis does not usually have a strong, well-established link with common illnesses like diabetes or heart disease. Its main overlap is with other blood vessel and soft-tissue conditions, because the affected areas can look similar to venous malformations or other lumps, especially when doctors are sorting out the early symptoms of glomangiomatosis. Doctors call it a comorbidity when two conditions occur together. For many living with glomangiomatosis, the bigger issue is that another health problem can make diagnosis or treatment more complicated; for example, blood-thinning medicines may increase bruising or bleeding, and arthritis or nerve problems can make pain harder to pinpoint. When glomangiomatosis involves deeper tissue near a joint, muscle, or nerve, ongoing swelling or pain can add to movement problems that may already be present from another condition. Because glomangiomatosis is rare, it often helps to have coordinated care so specialists can rule out other causes of painful swelling and plan treatment around your full health picture.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Glomangiomatosis?
Glomangiomatosis can be mistaken for other conditions that cause blue or purple skin spots or lumps and pain, especially venous malformations and glomuvenous malformations, which are problems in small veins, and hemangiomas, which are noncancerous growths made of extra blood vessels. Doctors may also think about a regular glomus tumor, blue rubber bleb nevus syndrome, or other harmless but painful soft-tissue lumps because they can look and feel similar. Since these conditions can overlap so much, scans and sometimes a small tissue sample may be needed to tell them apart.
History
People living with glomangiomatosis often spend years trying to name what they have. The condition can show up as clusters of painful bluish or purple spots in the skin or soft tissue, and in earlier eras these marks were often described only by how they looked or felt rather than by a clear diagnosis.
As medical science evolved, doctors began to separate glomangiomatosis from other blood vessel and soft tissue conditions that can look similar. Early reports grouped many of these growths together, which made the history a little confusing. Over time, better tissue studies under the microscope helped show that glomangiomatosis had its own pattern, including multiple related growths rather than a single isolated one.
That shift mattered for families. Instead of being told the spots were simply birthmarks, bruises, or an unusual vein problem, many living with glomangiomatosis could finally have the condition recognized more accurately. Not every early description was complete, yet together they helped build the modern picture of the disease and the way it may run in some families.
In more recent decades, imaging scans, pathology, and genetic research have made the diagnosis much more precise. Doctors now understand that glomangiomatosis belongs to a broader group of glomus-related conditions, but it has its own history and pattern of spread. Knowing this background can help explain why older medical records may use different names, and why diagnosis sometimes still takes time when the early symptoms of glomangiomatosis overlap with other skin or vascular conditions.